Category: Biotechnology
Biotechnology market research reports by Plunkett Research, Ltd.
-
Financial Analysis and Multi-Year Benchmarking: Cytek Biosciences Inc (CTKB:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Cytek Biosciences Inc (CTKB:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forCytek Biosciences Inc (CTKB:NAS) c ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Royalty Pharma PLC (RPRX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Royalty Pharma PLC (RPRX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forRoyalty Pharma PLC (RPRX:NAS) compare ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Spyre Therapeutics Inc (SYRE:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Spyre Therapeutics Inc (SYRE:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forSpyre Therapeutics Inc (SYRE:NAS) ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Cerus Corporation (CERS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Cerus Corporation (CERS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forCerus Corporation (CERS:NAS) compared ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Agenus Inc (AGEN:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Agenus Inc (AGEN:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forAgenus Inc (AGEN:NAS) compared to its top com ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Amgen Inc (AMGN:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Amgen Inc (AMGN:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forAmgen Inc (AMGN:NAS) compared to its top compe ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Benitec Biopharma Inc (BNTC:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Benitec Biopharma Inc (BNTC:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forBenitec Biopharma Inc (BNTC:NAS) c ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Cabaletta Bio Inc (CABA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Cabaletta Bio Inc (CABA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forCabaletta Bio Inc (CABA:NAS) compared ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Foghorn Therapeutics Inc (FHTX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Foghorn Therapeutics Inc (FHTX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forFoghorn Therapeutics Inc (FHTX: ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Krystal Biotech (KRYS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Krystal Biotech (KRYS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forKrystal Biotech (KRYS:NAS) compared to i ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Moderna Inc (MRNA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Moderna Inc (MRNA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forModerna Inc (MRNA:NAS) compared to its top c ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Aerovate Therapeutics Inc (AVTE:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Aerovate Therapeutics Inc (AVTE:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forAerovate Therapeutics Inc (AVT ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Viracta Therapeutics Inc (VIRX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Viracta Therapeutics Inc (VIRX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forViracta Therapeutics Inc (VIRX: ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Adaptive Biotechnologies Corporation (ADPT:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Adaptive Biotechnologies Corporation (ADPT:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forAdaptive Biotechnol ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Bionano Genomics Inc (BNGO:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Bionano Genomics Inc (BNGO:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forBionano Genomics Inc (BNGO:NAS) com ... Read More
-
Financial Analysis and Multi-Year Benchmarking: XOMA Corporation (XOMA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: XOMA Corporation (XOMA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forXOMA Corporation (XOMA:NAS) compared to ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Singular Genomics Systems Inc (OMIC:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Singular Genomics Systems Inc (OMIC:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forSingular Genomics Systems ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Puma Biotechnology Inc (PBYI:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Puma Biotechnology Inc (PBYI:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forPuma Biotechnology Inc (PBYI:NAS) ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Caribou Biosciences Inc (CRBU:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Caribou Biosciences Inc (CRBU:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forCaribou Biosciences Inc (CRBU:NA ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Charles River Laboratories International Inc (CRL:NYS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Charles River Laboratories International Inc (CRL:NYS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forCharles Rive ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Kronos Bio Inc (KRON:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Kronos Bio Inc (KRON:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forKronos Bio Inc (KRON:NAS) compared to its ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Celldex Therapeutics Inc (CLDX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Celldex Therapeutics Inc (CLDX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forCelldex Therapeutics Inc (CLDX: ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Fate Therapeutics Inc (FATE:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Fate Therapeutics Inc (FATE:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forFate Therapeutics Inc (FATE:NAS) c ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Ovid Therapeutics (OVID:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Ovid Therapeutics (OVID:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forOvid Therapeutics (OVID:NAS) compared ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Brainstorm Cell Therapeutics Inc (BCLI:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Brainstorm Cell Therapeutics Inc (BCLI:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forBrainstorm Cell Therape ... Read More
Research Assistance
